What is the effect of radioiodine therapy on Helicobacter pylori infection?

Creative Commons License

Usluogullari C. A. , Onal E. D. , Ozdemir E., Caner S., ERSOY O., ERSOY R., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.44, no.3, pp.520-523, 2014 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 3
  • Publication Date: 2014
  • Doi Number: 10.3906/sag-1301-142
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.520-523

Abstract

Background/aim: Helicobacter pylori is an important human pathogen associated with gastric and duodenal ulcers, gastric mucosa-associated lymphoid tissue lymphoma, and adenocarcinoma. Radioiodine (RAI) treatment plays an important role in the management of differentiated thyroid cancer and primary hyperthyroidism. It is known that during RAI treatment, a considerable amount is absorbed by the stomach as well. In this study we aimed to reveal any therapeutic impact of RAI on H. pylori infections.